<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="brief-report" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Palliat Med</journal-id><journal-id journal-id-type="iso-abbrev">J Palliat Med</journal-id><journal-id journal-id-type="pmc-domain-id">1161</journal-id><journal-id journal-id-type="pmc-domain">jpm</journal-id><journal-id journal-id-type="publisher-id">jpm</journal-id><journal-title-group><journal-title>Journal of Palliative Medicine</journal-title></journal-title-group><issn pub-type="ppub">1096-6218</issn><issn pub-type="epub">1557-7740</issn><publisher><publisher-name>Mary Ann Liebert, Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10316523</article-id><article-id pub-id-type="pmcid-ver">PMC10316523.1</article-id><article-id pub-id-type="pmcaid">10316523</article-id><article-id pub-id-type="pmcaiid">10316523</article-id><article-id pub-id-type="pmid">37074064</article-id><article-id pub-id-type="doi">10.1089/jpm.2022.0389</article-id><article-id pub-id-type="publisher-id">10.1089/jpm.2022.0389</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Brief Reports</subject></subj-group></article-categories><title-group><article-title>Efforts to Improve Naloxone Co-Prescription for Patients With Cancer Pain at Risk of Opioid Overdose</article-title><alt-title alt-title-type="left-running-head">AMARAM-DAVILA ET AL.</alt-title><alt-title alt-title-type="right-running-head">NALOXONE CO-PRESCRIPTION FOR PATIENTS WITH CANCER PAIN</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Amaram-Davila</surname><given-names initials="J">Jaya</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn1" ref-type="author-notes">
<sup>*</sup>
</xref><xref rid="corr1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reddy</surname><given-names initials="A">Akhila</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn1" ref-type="author-notes">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Arthur</surname><given-names initials="J">Joseph</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Narayanan</surname><given-names initials="S">Santhosshi</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gogineni</surname><given-names initials="M">Meghana</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mallipeddi</surname><given-names initials="T">Tarun</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>De Moraes</surname><given-names initials="AR">Aline Rozman</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Maddi</surname><given-names initials="R">Rama</given-names></name><degrees>MBA, MHA</degrees><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shelal</surname><given-names initials="Z">Zeena</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Urbauer</surname><given-names initials="D">Diana</given-names></name><degrees>MS</degrees><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="M">Minxing</given-names></name><degrees>MS</degrees><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bruera</surname><given-names initials="E">Eduardo</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><aff id="aff1"><label><sup>1</sup></label>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer, Houston, Texas, USA.</aff><aff id="aff2"><label><sup>2</sup></label>The University of Texas, University of Southwestern School of Medicine, Dallas, Texas, USA.</aff><aff id="aff3"><label><sup>3</sup></label>The University of Tennessee Health Science Center, Memphis, Tennessee, USA.</aff><aff id="aff4"><label><sup>4</sup></label>Department of Leukemia, The University of Texas MD Anderson Cancer, Houston, Texas, USA.</aff><aff id="aff5"><label><sup>5</sup></label>Department of Biostatistics, The University of Texas MD Anderson Cancer, Houston, Texas, USA.</aff></contrib-group><author-notes><fn id="fn1" fn-type="equal"><label>
<sup>*</sup>
</label><p>These authors contributed equally to this work.</p></fn><corresp id="corr1">Address correspondence to: Jaya Amaram-Davila, MD, Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer, 1515 Holcombe Boulevard, Unit 1414, Houston, TX 77030, USA <email>jsamaram@mdanderson.org</email></corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>7</month><year>2023</year><string-date>July 2023</string-date></pub-date><pub-date pub-type="epub"><day>29</day><month>6</month><year>2023</year></pub-date><volume>26</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">439744</issue-id><fpage>969</fpage><lpage>973</lpage><history><date date-type="accepted"><day>23</day><month>2</month><year>2023</year><string-date>Accepted February 23, 2023</string-date></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>07</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-07-01 00:25:30.177"><day>01</day><month>07</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023, Mary Ann Liebert, Inc., publishers</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Mary Ann Liebert, Inc., publishers</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jpm.2022.0389.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="jpm.2022.0389.pdf"/><abstract><sec id="S010"><title>Importance:</title><p>Naloxone can be lifesaving in an opioid-related overdose (OD). However, the co-prescription of take-home naloxone (THN) is not widely adopted in routine clinical practice. We implemented a pilot program focused on increasing clinicians' awareness of THN and observed if this impacts THN prescriptions for our patients with cancer pain receiving opioids.</p></sec><sec id="S011"><title>Intervention:</title><p>In January 2020, we initiated an educational program by twice-weekly video presentations and installed pamphlets in all clinic workstations highlighting the risk factors for ODs. We retrospectively reviewed electronic health records (EHR) of randomly selected patient visits, 200 each from eight weeks before intervention (BI) and eight weeks after the intervention (AI). Data on patient characteristics, risk factors for ODs, and THN prescriptions were collected.</p></sec><sec id="S012"><title>Results:</title><p>In all, 380 unique patients were eligible for analysis. The median age was 60, 53% female, and 70% Caucasian. Eighty-two percent (152) BI and 73% (142) AI carried risk factors for ODs (<italic toggle="yes">p</italic>&#8201;=&#8201;0.13). THN was prescribed to 21% (32/152) BI and 26% (37/142) AI (<italic toggle="yes">p</italic>&#8201;=&#8201;0.53). Morphine-equivalent daily dose (MEDD) &#8805;100&#8201;mg (30%) and pulmonary disease (25%) were the most prevalent risk factors. The patient's likelihood of receiving a THN prescription increased by 0.9% for every 1-milligram increase in MEDD (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, 95% confidence interval: 1.006&#8211;1.011).</p></sec><sec id="S013"><title>Conclusion:</title><p>The educational intervention did not significantly increase the frequency of THN prescriptions. More direct interventions, including automatic EHR triggers, may need to be tested in future trials.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>cancer pain</kwd><kwd>opioid overdoses</kwd><kwd>take-home naloxone</kwd></kwd-group><counts><table-count count="2"/><ref-count count="14"/><page-count count="5"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>